)

Quanterix (QTRX) investor relations material
Quanterix Canaccord Genuity’s 45th Annual Growth Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Business performance and guidance
Core business expected to decline meaningfully in 2025, with academic revenues down 18% and pharma impacted by smaller accelerator projects.
Consumables business remains resilient, with only a 4% year-over-year decline, and spatial business achieved its largest ever consumables quarter.
Accelerator business saw a 60% year-over-year revenue drop due to smaller project sizes and reduced biopharma spending, despite more trials and new customers.
Akoya's revenue decline attributed to CDx milestone timing and macroeconomic factors, with a projected annualized revenue of $65M.
Guidance has been pressure tested for current macro conditions, with potential upside if the environment improves.
Strategic initiatives and synergies
Integration of Akoya aims to create a unified company with one leadership and commercial team, focusing on assay development and expanding technology systems.
Targeting $85M in annualized run-rate synergies by 2026, with 75% already implemented, and a single operating footprint for efficiency.
Cash flow breakeven targeted for 2026, achievable even if macro conditions remain unchanged, driven by cost synergies.
R&D investment increased to 30% of revenues, focusing on customer continuity and growth.
Product development and innovation
Launching the Simoa One platform with enhanced sensitivity and multiplexing, targeting immunology and oncology applications.
Simoa One reagents to be made available to a broader flow cytometer installed base in 2026, enabling wider research access.
Lucent AD Complete, a five-marker Alzheimer's diagnostic test, is advancing toward FDA submission and Medicare reimbursement, with additional clinical utility studies planned.
New progression markers (205 and 212) launched for neurofibrillary tangle detection, enhancing diagnostic and monitoring capabilities.
Ongoing expansion of assay menu, leveraging synergies between neuro and oncology, and focusing on high-throughput, easy-to-use solutions.
Next Quanterix earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage